scispace - formally typeset
M

Maria Beatrice Morelli

Researcher at University of Camerino

Publications -  86
Citations -  7811

Maria Beatrice Morelli is an academic researcher from University of Camerino. The author has contributed to research in topics: Transient receptor potential channel & Cancer. The author has an hindex of 28, co-authored 74 publications receiving 6749 citations. Previous affiliations of Maria Beatrice Morelli include Sapienza University of Rome.

Papers
More filters
Journal ArticleDOI

Coexpression of TRPML1 and TRPML2 Mucolipin Channels Affects the Survival of Glioblastoma Patients

TL;DR: The double knockdown of TRP ML1 and TRPML2 leads to increased GBM cell survival with respect to single-channel-silenced cells, and improves migration and invasion ability of U251 cells.
Journal ArticleDOI

Calcium influx, oxidative stress, and apoptosis induced by TRPV1 in chronic myeloid leukemia cells: Synergistic effects with imatinib

TL;DR: In this paper , the activation of transient receptor potential vanilloid 1, by Noleoyl-dopamine, in chronic myeloid leukemia cell lines was investigated, and the activation induced calcium influx, oxidative stress, ER stress, mitochondria dysfunction, and caspase activation.
Journal ArticleDOI

Emerging Role of TRPML1 Mucolipin Endolysosomal Channel in Cancer

TL;DR: interesting and recent data are presented suggesting for an important role played by TRPML1 in cancer, both up and down-regulation of TRP ML1 mRNA and protein expression is associated with different cancer types.
Journal ArticleDOI

Different effects of sunitinib, sorafenib, and pazopanib on inducing cancer cell death: The role of autophagy.

TL;DR: Different TKI-induced cell death mechanisms provide the rationale for the sequential use of these agents and the biological basis for novel molecularly targeted approaches.
Journal ArticleDOI

Unveiling the Molecular Mechanisms Driving the Capsaicin-Induced Immunomodulatory Effects on PD-L1 Expression in Bladder and Renal Cancer Cell Lines

TL;DR: There is a rationale for CPS exploitation as a stimulus that increases BC cells’ response to immunotherapy or as an immune adjuvant to improve the efficacy of the conventional therapy in RCC patients, and results show that CPS mediates a multi-faceted approach.